MentiNova Overview
- Year Founded
-
2012

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MentiNova General Information
Description
Developer of drugs designed to treat Parkinson's disease. The company's drugs offer treatment for the neurodegenerative disorder and mental diseases, enabling healthcare providers to treat their patients and improve their lives.
Contact Information
Website
www.mentinova.comCorporate Office
- 155 Village Boulevard
- Suite 130
- Princeton, NJ 08540
- United States
Corporate Office
- 155 Village Boulevard
- Suite 130
- Princeton, NJ 08540
- United States
MentiNova Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 17-Nov-2020 | Completed | Out of Business | |||
1. Seed Round | 25-Jan-2013 | Completed | Generating Revenue |
MentiNova Patents
MentiNova Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150352099-A1 | Compositions and methods of reducing sedation | Inactive | 04-Jun-2014 |
MentiNova FAQs
-
When was MentiNova founded?
MentiNova was founded in 2012.
-
Where is MentiNova headquartered?
MentiNova is headquartered in Princeton, NJ.
-
What industry is MentiNova in?
MentiNova’s primary industry is Drug Discovery.
-
Is MentiNova a private or public company?
MentiNova is a Private company.
-
What is MentiNova’s current revenue?
The current revenue for MentiNova is
. -
How much funding has MentiNova raised over time?
MentiNova has raised $500K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »